Clinical Trial Update: Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating DEB-BACE with sequential arotinib and tirelizumab for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• DEB-BACE
• Tirelizumab (tirelizumab)
• arotinib (Apatinib)

Snippet

Sponsor: Gang Wu | Conditions: Carcinoma, Non-Small Cell Lung | Phase 2 | Status: UNKNOWN